CN106266275A - The Chinese medicine preparation for the treatment of erysipelas - Google Patents
The Chinese medicine preparation for the treatment of erysipelas Download PDFInfo
- Publication number
- CN106266275A CN106266275A CN201510287567.6A CN201510287567A CN106266275A CN 106266275 A CN106266275 A CN 106266275A CN 201510287567 A CN201510287567 A CN 201510287567A CN 106266275 A CN106266275 A CN 106266275A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- erysipelas
- chinese medicine
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 201000000297 erysipelas Diseases 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 241000746375 Andrographis Species 0.000 claims abstract description 5
- 239000010231 banlangen Substances 0.000 claims abstract description 4
- 229940023488 Pill Drugs 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000002552 dosage form Substances 0.000 claims abstract description 3
- 239000008187 granular material Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 210000004369 Blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 4
- 238000001816 cooling Methods 0.000 abstract description 2
- 229940079593 drugs Drugs 0.000 abstract description 2
- 238000001784 detoxification Methods 0.000 abstract 1
- 230000027939 micturition Effects 0.000 abstract 1
- 230000001737 promoting Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 231100000614 Poison Toxicity 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 6
- 230000001717 pathogenic Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000005679 Eczema Diseases 0.000 description 3
- 201000004624 dermatitis Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 231100001003 eczema Toxicity 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N Baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 210000003026 Hypopharynx Anatomy 0.000 description 2
- JQNVCUBPURTQPQ-FTWMDKANSA-N Inokosterone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CC[C@H](CO)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 JQNVCUBPURTQPQ-FTWMDKANSA-N 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N Isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- MAYJEFRPIKEYBL-YABUPPFZSA-N Obacunone Natural products O=C1O[C@@H](c2cocc2)[C@@]2(C)[C@]3([C@]4(C)C(=O)C[C@@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]4CC2)O[C@@H]13 MAYJEFRPIKEYBL-YABUPPFZSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 206010040943 Skin ulcer Diseases 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 201000000736 amenorrhea Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- OBVZFHXNNMIIRJ-HBCLNWRISA-N (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-5-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)-6-oxohexanoic acid Chemical compound COC1=C([C@](O)(C=O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 OBVZFHXNNMIIRJ-HBCLNWRISA-N 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 208000001780 Epistaxis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 210000003414 Extremities Anatomy 0.000 description 1
- 229940097043 Glucuronic Acid Drugs 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 229940097275 Indigo Drugs 0.000 description 1
- 240000007871 Indigofera tinctoria Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 210000000214 Mouth Anatomy 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 241000257673 Strobilanthes cusia Species 0.000 description 1
- VXMKYRQZQXVKGB-CWWHNZPOSA-N Tannin Chemical compound O([C@H]1[C@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]([C@H]2O)O1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 VXMKYRQZQXVKGB-CWWHNZPOSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-OAHLLOKOSA-N [(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-OAHLLOKOSA-N 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000001605 fetal Effects 0.000 description 1
- 235000021285 flavonoid Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- -1 mucus Matter Substances 0.000 description 1
- 230000001473 noxious Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
Abstract
A kind of Chinese medicine preparation treating erysipelas, belongs to technical field of traditional Chinese medicine preparation.It is mainly made up of Radix Scutellariae, Cortex Phellodendri, Radix Arnebiae (Radix Lithospermi), Radix Paeoniae Rubra, Radix Isatidis, Radix Achyranthis Bidentatae, Herba Andrographis, 8 kinds of crude drug of Herba Violae.The different dosage forms such as capsule, tablet, granule, pill, oral liquid are made standby with pharmacy apparatus.The present invention has effect of clearing away heat and cooling blood, detoxification and promoting urination, and treatment erysipelas is effective.Taking convenience, safely and effectively.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
, from the beginning of fever with aversion to cold, there is erythema, hot swelling then in erysipelas on skin, color is such as coated with pellet, fading of pressure, lets go
I.e. restore shape, often spread to surrounding rapidly, blister occurs, the scorchinggest hot pain, clear-cut margin, slightly higher go out normal surface, have
Sepage.Modern medicine treatment to this disease at present generally uses antimicrobial drug.But owing to abusing antimicrobial drug in recent years, make pathogenic bacteria produce
Drug resistance, adds the treatment difficulty of toxic and side effects.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that a kind of Chinese medicine preparation treating erysipelas.It has heat clearing away
Dampness removing, the function of removing toxic substances removing heat from blood, treatment erysipelas is effective.Taking convenience, safely and effectively purpose can be reached.
The technical solution adopted for the present invention to solve the technical problems is: by Radix Scutellariae, Cortex Phellodendri, Radix Arnebiae (Radix Lithospermi), Radix Paeoniae Rubra, Baphicacanthus cusia
Root, Radix Achyranthis Bidentatae, Herba Andrographis, 8 kinds of crude drug of Herba Violae are constituted.
Invention formulation relevant pharmaceutical compositions major function and preparation.
Radix Scutellariae in the present invention, nature and flavor are bitter, cold.Containing baicalin, wogonoside, glucuronic acid, enzyme etc..Clearing away damp-heat,
Purte the white, antiabortive removing toxic substances.Cure mainly jaundice due to damp-heat, cough due to lung-heat, ulcer sores, frequent fetal movement.
Cortex Phellodendri in the present invention, nature and flavor are bitter, cold.Containing phellodendrine, Palmic acid, fatty oil, obacunone, phlegmatic temperament, steroid
Alcohol etc..Reducing the minister-fire, dehumidifying heat.Curing mainly aphtha of the mouth and tongue, conjunctival congestion tinnitus, hematodiarrhoea is had loose bowels, osteopyrexia and fever, jaundice, stranguria with turbid discharge, just
Blood, leucorrhea with red and white discharge, noxious dampness skin infection.
Radix Arnebiae (Radix Lithospermi) in the present invention, nature and flavor are bitter, cold.Containing acetylshikonin, Radix Arnebiae (Radix Lithospermi) is red.Removing heat from blood, invigorates blood circulation, and expelling pathogenic factors from the exterior detoxifies.
Cure mainly macule eczema, erysipelas, carbuncle, sore.External treatment skin eczema ulcer.
Radix Paeoniae Rubra in the present invention, nature and flavor are sour, bitter, are slightly cold.Containing benzoic acid, paeoniflorin, starch, tannin, mucus
Matter, pigment etc..Removing blood stasis and activating blood flow, pain relieving, removing fire from the liver.Curing mainly menoxenia, the stasis of blood is stagnant, stomachache, amenorrhea lump in the abdomen, carbuncle skin ulcer
Poison, chest and hypochondrium, conjunctival congestion.
Radix Isatidis in the present invention, nature and flavor are bitter, cold.Containing aminoacid, indigo glycoside, meson glycoside, isatin etc..Clearing away heat and cooling blood, disappears
Swollen removing toxic substances.Cure mainly calentura and send out speckle, erysipelas, laryngopharynx swelling and pain, epidemic infection with swollen head, spit blood, epistaxis.
Radix Achyranthis Bidentatae in the present invention, nature and flavor are micro-sweet, puckery, flat.Containing inokosterone, triterpenoid saponin, potassium salt, phlegmatic temperament etc..
Dissipating blood stasis blood is used in life.Ripe invigorating the liver and kidney.Cure mainly soreness of waist and knee joint thin and weak, spasm of the limbs, amenorrhea lump in the abdomen, postnatal blood stasis stomachache, blood
Drench, traumatic injury.
Herba Andrographis in the present invention, nature and flavor are bitter, cold.Return lung, stomach, large intestine, small intestine meridian.Heat-clearing and toxic substances removing, dampness.Cure mainly
Lung-heat, cough, the epilepsy due to deficiency of the lung, laryngopharynx swelling and pain, damp-heat dysentery, pyretic stranguria, eczema.
Herba Violae in the present invention, nature and flavor are bitter, cold.Containing glycoside, flavonoid, wax etc..Heat-clearing and toxic substances removing.Cure mainly carbuncle skin ulcer
Infections, scrofula malignant boil.
The etiology and pathogenesis of erysipelas is blood system latent heat, diseases caused by exogenous pathogenic factor rheumatism pathogenic heat, inside and outside combined pathogens and cause a disease.The present invention has heat clearing away profit
Wet, effect of removing toxic substances removing heat from blood, treatment erysipelas is effective.The invention has the beneficial effects as follows and clinic application proves that determined curative effect, peace
Atoxic side effect.
Detailed description of the invention
1, formula and part by weight: Radix Scutellariae 15 parts, Cortex Phellodendri 18 parts, Radix Arnebiae (Radix Lithospermi) 16 parts, Radix Paeoniae Rubra 15 parts, Radix Isatidis
20 parts, Radix Achyranthis Bidentatae 15 parts, Herba Andrographis 18 parts, Herba Violae 20 parts.
2, manufacture method: weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, purifies and concentrates
The different dosage forms such as capsule, tablet, granule, pill, oral liquid are made standby after mix homogeneously.
Claims (1)
1. treat a Chinese medicine preparation for erysipelas, it is characterized in that formula and part by weight are Radix Scutellariae 15 parts, Cortex Phellodendri
18 parts, Radix Arnebiae (Radix Lithospermi) 16 parts, Radix Paeoniae Rubra 15 parts, Radix Isatidis 20 parts, Radix Achyranthis Bidentatae 15 parts, Herba Andrographis 18 parts,
Herba Violae 20 parts；Being weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, carries
The different dosage forms such as capsule, tablet, granule, pill, oral liquid are made standby after pure concentration mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510287567.6A CN106266275A (en) | 2015-05-25 | 2015-05-25 | The Chinese medicine preparation for the treatment of erysipelas |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510287567.6A CN106266275A (en) | 2015-05-25 | 2015-05-25 | The Chinese medicine preparation for the treatment of erysipelas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106266275A true CN106266275A (en) | 2017-01-04 |
Family
ID=57654965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510287567.6A Pending CN106266275A (en) | 2015-05-25 | 2015-05-25 | The Chinese medicine preparation for the treatment of erysipelas |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106266275A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785554A (en) * | 2018-08-09 | 2018-11-13 | 陈冠卿 | A kind of tablet for treating snake-eye furuncle |
-
2015
- 2015-05-25 CN CN201510287567.6A patent/CN106266275A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785554A (en) * | 2018-08-09 | 2018-11-13 | 陈冠卿 | A kind of tablet for treating snake-eye furuncle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104606385A (en) | Traditional Chinese medicine preparation for treating paronychia | |
| CN103566242B (en) | A kind of Chinese medicinal ointment for the treatment of verruca plana | |
| CN103610964A (en) | Medicine for treating recurrent oral ulcer | |
| CN106266275A (en) | The Chinese medicine preparation for the treatment of erysipelas | |
| CN105521082A (en) | Traditional Chinese medicinal preparation for treating eczema with syndrome of wind heat | |
| CN103463401B (en) | Asthma medicine for infants | |
| CN106266650A (en) | The ointment for the treatment of erysipelas | |
| CN105770115A (en) | Traditional Chinese medicine ointment for treating eczema | |
| CN105477199A (en) | Chinese patent medicine for treating liver-depression dryness-heat verruca plana | |
| CN106177658A (en) | The outer applying liquid for the treatment of erysipelas | |
| CN105878557A (en) | Herbal preparation for treating seborrhea dermatitis due to yin-deficiency stagnation | |
| CN106177068A (en) | The emulsifiable paste for the treatment of red wandering erysipelas | |
| CN101095913A (en) | Chinese medicine preparation for treating diabetes cholecystitis | |
| CN104840823A (en) | Traditional Chinese medicine preparation for treating otitis media and preparation method | |
| CN105535202A (en) | Solution for treating flat warts of limb under parts | |
| CN104306806A (en) | Traditional Chinese medicine composition for treating eczema | |
| CN104644892A (en) | Cutaneous anthrax treating drug | |
| CN106177070A (en) | A kind of Chinese medicine composition treating lower limb erysipelas | |
| CN103463403B (en) | Pharmaceutical composition for infantile asthma | |
| CN103656093B (en) | Be used for the treatment of medicine of Sanguis sus domestica dysentery and preparation method thereof | |
| CN106266075A (en) | The medicine for the treatment of erysipelas in the lower part of the trunk | |
| CN102813854B (en) | Chinese herbal medicine paste used for treating acne | |
| CN106177656A (en) | The Bathing lotion for the treatment of erysipelas | |
| CN109303825A (en) | A kind of Chinese medicine composition for treating jock itch | |
| CN106177259A (en) | A kind of cream treating lower limb erysipelas is stuck with paste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |